We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 61-80 of 1,261 results
  1. Progress of Mitochondrial Function Regulation in Cardiac Regeneration

    Heart failure and myocardial infarction, global health concerns, stem from limited cardiac regeneration post-injury. Myocardial infarction, typically...

    Yi-** Chen, An-Ran Zhao, ... Lian-Sheng Wang in Journal of Cardiovascular Translational Research
    Article 22 April 2024
  2. Metabolism-secretion coupling in glucose-stimulated insulin secretion

    Pancreatic β-cells in the islets of Langerhans secrete insulin in response to blood glucose levels. Precise control of the amount of insulin secreted...

    Hisamitsu Ishihara in Diabetology International
    Article 19 March 2022
  3. Mitochondrial Genetics and Function as Determinants of Bone Phenotype and Aging

    Purpose of Review

    The purpose of this review is to summarize the recently published scientific literature regarding the effects of mitochondrial...

    Sarah E. Catheline, Ethan Kaiser, Roman A. Eliseev in Current Osteoporosis Reports
    Article 05 August 2023
  4. IDH2 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in multiple myeloma

    Epigenetic alterations have been previously shown to contribute to multiple myeloma (MM) pathogenesis via DNA methylations and histone modifications....

    Sha Song, Gao Fan, ... Wenzhuo Zhuang in Oncogene
    Article 17 July 2021
  5. Glutamine stabilizes myc via alpha-ketoglutarate and regulates paclitaxel sensitivity

    Metabolic reprogramming wherein the cancer cells exhibit altered energetics is a hallmark of cancer. Although recent discoveries have enhanced our...

    Vikas Bhardwaj, Jun He, Aditi Jain in Medical Oncology
    Article 29 September 2022
  6. Pharmacokinetics/pharmacodynamics of ivosidenib in advanced IDH1-mutant cholangiocarcinoma: findings from the phase III ClarIDHy study

    Purpose

    Report pharmacokinetic (PK)/pharmacodynamic (PD) findings from the phase III ClarIDHy study and any association between PK/PD parameters and...

    Bin Fan, Ghassan K. Abou-Alfa, ... Hua Yang in Cancer Chemotherapy and Pharmacology
    Article Open access 27 January 2024
  7. TNFα-induced IDH1 hyperacetylation reprograms redox homeostasis and promotes the chemotherapeutic sensitivity

    The heterogeneity and drug resistance of colorectal cancer (CRC) often lead to treatment failure. Isocitrate dehydrogenase 1 (IDH1), a rate-limiting...

    Hao Yang, ** Zhao, ... Gang Huang in Oncogene
    Article 10 November 2022
  8. Therapies for IDH-Mutant Gliomas

    Purpose of Review

    Isocitrate dehydrogenase ( IDH ) mutant gliomas are a distinct type of primary brain tumors with unique characteristics, behavior,...

    Ruham Alshiekh Nasany, Macarena Ines de la Fuente in Current Neurology and Neuroscience Reports
    Article Open access 15 April 2023
  9. Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer

    Cardiovascular disease and cancer are the two leading causes of morbidity and mortality in the world. The emerging field of cardio-oncology has...

    Anja Karlstaedt, Javid Moslehi, Rudolf A. de Boer in Nature Reviews Cardiology
    Article 19 April 2022
  10. Association between protein undernutrition and diabetes: Molecular implications in the reduction of insulin secretion

    Undernutrition is still a recurring nutritional problem in low and middle-income countries. It is directly associated with the social and economic...

    Thiago dos Reis Araujo, Bruna Lourençoni Alves, ... Everardo Magalhães Carneiro in Reviews in Endocrine and Metabolic Disorders
    Article 04 December 2023
  11. The evolving landscape of monogenic nephrolithiasis and therapeutic innovations

    Chen-Han Wilfred Wu, Yu-Ren Huang, ... Friedhelm Hildebrandt in Nature Reviews Urology
    Article 17 April 2024
  12. Perturbed epigenetic transcriptional regulation in AML with IDH mutations causes increased susceptibility to NK cells

    Isocitrate dehydrogenase (IDH) mutations are found in 20% of acute myeloid leukemia (AML) patients. However, only 30–40% of the patients respond to...

    Anna Palau, Filip Segerberg, ... Andreas Lennartsson in Leukemia
    Article Open access 26 July 2023
  13. Antiepileptic Strategies for Patients with Primary and Metastatic Brain Tumors

    Seizure activity is common in patients with primary and metastatic brain tumors, affecting more than 50% of cases over the course of their disease....

    Herbert B. Newton, Jenna Wojkowski in Current Treatment Options in Oncology
    Article Open access 14 February 2024
  14. Changes of energy metabolism in failing heart and its regulation by SIRT3

    Heart failure (HF) is the leading cause of hospitalization in elderly patients and a disease with extremely high morbidity and mortality rate...

    **ao Wang, Yuting Huang, ... **gyu Ni in Heart Failure Reviews
    Article 28 January 2023
  15. Mitochondrial Damage and Hypertension: Another Dark Side of Sodium Excess

    Purpose of Review

    Essential or primary hypertension (HT) is a worldwide health problem with no definitive cure. Although the exact pathogenesis of HT...

    Baris Afsar, Rengin Elsurer Afsar in Current Nutrition Reports
    Article 29 June 2023
  16. Differential expression of the BCAT isoforms between breast cancer subtypes

    Background

    Biological characterisation of breast cancer subtypes is essential as it informs treatment regimens especially as different subtypes have...

    Mai Ahmed Shafei, Arwa Flemban, ... Myra E. Conway in Breast Cancer
    Article Open access 24 December 2020
  17. GLUD1 inhibits hepatocellular carcinoma progression via ROS-mediated p38/JNK MAPK pathway activation and mitochondrial apoptosis

    Glutamate dehydrogenase 1 (GLUD1) is an important enzyme in glutamine metabolism. Previously, we found GLUD1 was down-regulated in tumor tissues of...

    Qianwei Zhao, Mengdan Yu, ... **tao Zhang in Discover Oncology
    Article Open access 12 January 2024
Did you find what you were looking for? Share feedback.